118 related articles for article (PubMed ID: 38795810)
41. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
[TBL] [Abstract][Full Text] [Related]
42. Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in Colorectal Cancer.
Tian X; He Y; Qi L; Liu D; Zhou D; Liu Y; Gong W; Han Z; Xia Y; Li H; Wang J; Zhu K; Chen L; Guo H; Zhao Q
Int J Biol Sci; 2023; 19(9):2817-2834. PubMed ID: 37324947
[TBL] [Abstract][Full Text] [Related]
43. mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism.
Lampada A; O'Prey J; Szabadkai G; Ryan KM; Hochhauser D; Salomoni P
Cell Death Differ; 2017 Jun; 24(6):1045-1062. PubMed ID: 28475179
[TBL] [Abstract][Full Text] [Related]
44. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
45. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
46. Amino acid substitution in the C-terminal domain of collagen XVII reduces laminin-332 interaction causing mild skin fragility with atrophic scarring.
Kroeger J; Hoppe E; Galiger C; Has C; Franzke CW
Matrix Biol; 2019 Jul; 80():72-84. PubMed ID: 30316981
[TBL] [Abstract][Full Text] [Related]
47. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
48. Activation of Rictor/mTORC2 signaling acts as a pivotal strategy to protect against sensorineural hearing loss.
Fu X; Li P; Zhang L; Song Y; An Y; Zhang A; Liu W; Ye C; Zhang Y; Yue R; Sun X; Chai R; Wang H; Gao J
Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2107357119. PubMed ID: 35238644
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways.
Liu YD; Ji CB; Li SB; Yan F; Gu QS; Balic JJ; Yu L; Li JK
Int Immunopharmacol; 2018 Jun; 59():375-383. PubMed ID: 29689497
[TBL] [Abstract][Full Text] [Related]
50. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
Dan HC; Antonia RJ; Baldwin AS
Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
[TBL] [Abstract][Full Text] [Related]
51. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
[TBL] [Abstract][Full Text] [Related]
52. Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling.
Liu Y; Chen Z; Cheng H; Chen J; Qian J
Oncotarget; 2017 Jan; 8(1):979-987. PubMed ID: 27894090
[TBL] [Abstract][Full Text] [Related]
53. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway.
Yu J; Liu M; Liu H; Zhou L
Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
[TBL] [Abstract][Full Text] [Related]
54. A20 interacts with mTORC2 to inhibit the mTORC2/Akt/Rac1 signaling axis in hepatocellular carcinoma cells.
Wang X; Xiao Y; Dong Y; Wang Z; Yi J; Wang J; Wang X; Zhou H; Zhang L; Shi Y
Cancer Gene Ther; 2023 Mar; 30(3):424-436. PubMed ID: 36411371
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
56. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
Chern Y; Zhang P; Ju H; Tai IT
Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
[No Abstract] [Full Text] [Related]
57. Rupatadine inhibits colorectal cancer cell proliferation through the PIP5K1A/Akt/CDK2 pathway.
Jiang L; Zhang Z; Luo Z; Li L; Yuan S; Cui M; He K; Xiao J
Biomed Pharmacother; 2024 Jul; 176():116826. PubMed ID: 38838507
[TBL] [Abstract][Full Text] [Related]
58. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
59. IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway.
Chen S; Han Q; Wang X; Yang M; Zhang Z; Li P; Chen A; Hu C; Li S
Cell Death Dis; 2013 Oct; 4(10):e842. PubMed ID: 24113176
[TBL] [Abstract][Full Text] [Related]
60. SPOCK1 is up-regulated and promotes tumor growth via the PI3K/AKT signaling pathway in colorectal cancer.
Zhang J; Zhi X; Shi S; Tao R; Chen P; Sun S; Bian L; Xu Z; Ma L
Biochem Biophys Res Commun; 2017 Jan; 482(4):870-876. PubMed ID: 27889608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
